These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12875794)

  • 1. Efficacy of simvastatin and ezetimibe in treating hypercholesterolemia.
    Davidson MH
    J Am Coll Cardiol; 2003 Jul; 42(2):398-9; author reply 399. PubMed ID: 12875794
    [No Abstract]   [Full Text] [Related]  

  • 2. Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.
    Davidson MH
    Cleve Clin J Med; 2008 Jul; 75(7):479-82, 486-8, 490-1. PubMed ID: 18646584
    [No Abstract]   [Full Text] [Related]  

  • 3. The ENHANCE trial.
    Fee WH
    Cleve Clin J Med; 2008 Nov; 75(11):763; author reply 767. PubMed ID: 19068956
    [No Abstract]   [Full Text] [Related]  

  • 4. The ENHANCE trial.
    Porat G
    Cleve Clin J Med; 2008 Nov; 75(11):763, 767; author reply 767. PubMed ID: 19086111
    [No Abstract]   [Full Text] [Related]  

  • 5. LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemia.
    Brohet C; Banai S; Alings AM; Massaad R; Davies MJ; Allen C
    Curr Med Res Opin; 2005 Apr; 21(4):571-8. PubMed ID: 15899106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The implications of the ezetimibe and simvastatin in hypercholesterolemia enhances atherosclerosis regression trial: a return to first principles.
    Musunuru K; Blumenthal RS
    Clin Cardiol; 2008 Jun; 31(6):288-90. PubMed ID: 18543313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L; Reyes R; Johnson-Levonas AO; Sapre A; Tribble DL; Musliner T
    Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [LDL cholesterol lowering therapy: no target value but personalised treatment].
    Simoons ML; Deckers JW
    Ned Tijdschr Geneeskd; 2015; 159():A8770. PubMed ID: 25923500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination.
    Neal RC; Jones PH
    Vasc Health Risk Manag; 2006; 2(1):31-8. PubMed ID: 17319467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [IMPROVE-IT Study proves effectiveness of ezetimib. The Higgs particle of lipidologists].
    Einecke D
    MMW Fortschr Med; 2014 Dec; 156(21-22):24-6. PubMed ID: 25608385
    [No Abstract]   [Full Text] [Related]  

  • 11. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E;
    J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease.
    Farnier M; Volpe M; Massaad R; Davies MJ; Allen C
    Int J Cardiol; 2005 Jul; 102(2):327-32. PubMed ID: 15982505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
    Goldberg RB; Guyton JR; Mazzone T; Weinstock RS; Polis A; Edwards P; Tomassini JE; Tershakovec AM
    Mayo Clin Proc; 2006 Dec; 81(12):1579-88. PubMed ID: 17165637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of effects of morning versus evening administration of ezetimibe/simvastatin on serum cholesterol in patients with primary hypercholesterolemia.
    Yoon HS; Kim SH; Kim JK; Ko SH; Ko JE; Park SJ; Park MG; Lee JH; Hyon MS
    Ann Pharmacother; 2011 Jul; 45(7-8):841-9. PubMed ID: 21693699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials.
    Catapano A; Brady WE; King TR; Palmisano J
    Curr Med Res Opin; 2005 Jul; 21(7):1123-30. PubMed ID: 16004682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.
    Daskalopoulou SS; Mikhailidis DP
    Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T; Ballantyne C; Sisk C; Shah A; Veltri E; Maccubbin D
    Am J Cardiol; 2007 Jun; 99(12):1706-1713. PubMed ID: 17560879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
    Davidson MH; McGarry T; Bettis R; Melani L; Lipka LJ; LeBeaut AP; Suresh R; Sun S; Veltri EP
    J Am Coll Cardiol; 2002 Dec; 40(12):2125-34. PubMed ID: 12505224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
    Robinson JG; Ballantyne CM; Grundy SM; Hsueh WA; Parving HH; Rosen JB; Adewale AJ; Polis AB; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2009 Jun; 103(12):1694-702. PubMed ID: 19539078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.